Ludovic Decultot

Ludovic Decultot has extensive experience in medicinal chemistry and scientific research. Ludovic is currently a Senior Scientist at Treeline Biosciences, where they specialize in medicinal chemistry. Prior to this, they worked at Syros Pharmaceuticals as a Senior Scientist and Scientist II in medicinal chemistry. Ludovic also has experience as a Medicinal Chemist and Research Scientist at the Broad Institute of MIT and Harvard. Ludovic completed a postdoctoral fellowship at Harvard University and obtained their Ph.D. in synthetic chemistry from The University of Glasgow. Ludovic also worked as a visiting researcher at Harvard University and as a research assistant at Infinity Pharmaceuticals. Ludovic began their career as a trainee at IBA.

Ludovic Decultot's education history includes the following:

- In 2018, Ludovic attended Drew University for the Residential School on Medicinal Chemistry and Biology in Drug Discovery.

- From 2012 to 2016, Ludovic pursued a Doctor of Philosophy (Ph.D.) degree in Synthetic Chemistry at the University of Glasgow.

- In 2012, Ludovic obtained a Master of Science (M.Sci.) degree in Organic Synthesis and Chemistry of Bioactive Molecules from Université Claude Bernard Lyon 1.

- Starting from 2008 and ending in 2012, Ludovic studied at CPE Lyon, earning both a Master of Science and a Bachelor of Science degrees in Chemistry and Chemical Engineering.

- Ludovic attended Stanislas Cannes from 1999 to 2006, completing their high school education.

In addition to the mentioned academic achievements, Ludovic Decultot obtained a certification in Schrödinger's "Introduction to Molecular Modeling in Drug Discovery" from Schrödinger in April 2020.